{[(2R,3S,4S,5R,6R)-2-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-3,5-dihydroxy-6-(methylsulfanyl)oxan-4-yl]oxy}phosphonic acid

• ChemBase编号: 164844
• 分子式: C18H34ClN2O8PS
• 平均质量: 504.962921
• 单一同位素质量: 504.14620137
• SMILES: [C@@H]([C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)SC)O)OP(=O)(O)O)O)([C@H](Cl)C)NC(=O)[C@@H]1C[C@@H](CN1C)CCC
• Canonical SMILES: CCC[C@@H]1CN([C@@H](C1)C(=O)N[C@H]([C@H]1O[C@H](SC)[C@@H]([C@@H]([C@H]1O)OP(=O)(O)O)O)[C@H](Cl)C)C
• InChI: InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)16(29-30(25,26)27)14(23)18(28-15)31-4/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9?,10-,11+,12?,13+,14-,15-,16+,18-/m1/s1
• InChIKey: ZMGZEXFHZBYORP-YKCZRWSYSA-N

名称和登记号

名称

• IUPAC标准名: {[(2R,3S,4S,5R,6R)-2-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-3,5-dihydroxy-6-(methylsulfanyl)oxan-4-yl]oxy}phosphonic acid
• IUPAC传统名: [(2R,3S,4S,5R,6R)-2-[(1S,2S)-2-chloro-1-{[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]formamido}propyl]-3,5-dihydroxy-6-(methylsulfanyl)oxan-4-yl]oxyphosphonic acid
• 别名: (2S-trans)-7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galactooctopyranoside Methyl 3-(Dihydrogen Phosphate); Clindamycin 3-PhosphateDISCONTINUED

登记号

• CAS号: 28708-34-1
• PubChem SID: 162258978
• PubChem CID: 71314905

理论计算性质

• Acid pKa: 1.1426376
• 质子受体: 8
• 质子供体: 5
• LogD (pH = 5.5): -0.65001553
• LogD (pH = 7.4): -1.97956
• Log P: -0.5672014
• 摩尔折射率: 116.5902 cm^3
• 极化性: 47.154106 Å^3
• 极化表面积: 148.79 Å^2
• 可自由旋转的化学键: 9
• 里宾斯基五规则: false

详细说明

Toronto Research Chemicals - C580015

Clindamycin (C580000) impurity.

参考文献

• Coats, J.H., et al.: J. Bacteriology, 108, 459 (1971)
• Brown, L.W., et al.: J. Pharma. Sci., 67, 1254 (1971)